BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34581294)

  • 1. Menopausal hormone therapy and risk of incident hypertension: role of the route of estrogen administration and progestogens in the E3N cohort.
    Madika AL; MacDonald CJ; Fournier A; Mounier-Vehier C; Béraud G; Boutron-Ruault MC
    Menopause; 2021 Sep; 28(11):1204-1208. PubMed ID: 34581294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort.
    de Lauzon-Guillain B; Fournier A; Fabre A; Simon N; Mesrine S; Boutron-Ruault MC; Balkau B; Clavel-Chapelon F
    Diabetologia; 2009 Oct; 52(10):2092-100. PubMed ID: 19629429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
    Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
    J Clin Oncol; 2009 Nov; 27(31):5138-43. PubMed ID: 19752341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Female hormonal exposures and risk of rheumatoid arthritis in the French E3N-EPIC cohort study.
    Salliot C; Nguyen Y; Gusto G; Gelot A; Gambaretti J; Mariette X; Boutron-Ruault MC; Seror R
    Rheumatology (Oxford); 2021 Oct; 60(10):4790-4800. PubMed ID: 33547777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
    Canonico M; Fournier A; Carcaillon L; Olié V; Plu-Bureau G; Oger E; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Scarabin PY
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is breast cancer risk the same for all progestogens?
    Stute P
    Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Menopause and risk of thromboembolic events. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
    Hugon-Rodin J; Perol S; Plu-Bureau G
    Gynecol Obstet Fertil Senol; 2021 May; 49(5):455-461. PubMed ID: 33757918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
    Yuk JS; Kim T; Cho H; Gwak G
    Eur J Endocrinol; 2024 Jan; 190(1):1-11. PubMed ID: 38128117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992-2008.
    Fournier A; Dossus L; Mesrine S; Vilier A; Boutron-Ruault MC; Clavel-Chapelon F; Chabbert-Buffet N
    Am J Epidemiol; 2014 Sep; 180(5):508-17. PubMed ID: 25008104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone therapy formulation, dose, route of delivery, and risk of hypertension: findings from the Women's Health Initiative Observational Study (WHI-OS).
    Wild RA; Larson JC; Crandall CJ; Shadyab AH; Allison M; Gass M; Shufelt C; Manson JE
    Menopause; 2021 Jul; 28(10):1108-1116. PubMed ID: 34313617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?
    Morois S; Fournier A; Clavel-Chapelon F; Mesrine S; Boutron-Ruault MC
    Eur J Epidemiol; 2012 Jun; 27(6):439-52. PubMed ID: 22644109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
    Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
    Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
    Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L
    Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study.
    Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Savoye I; Boutron-Ruault MC; Fournier A; Kvaskoff M
    Int J Cancer; 2019 Oct; 145(7):1754-1767. PubMed ID: 30671928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid consumption and incident type 2 diabetes: an 18-year follow-up in the female E3N (Etude Epidémiologique auprès des femmes de la Mutuelle Générale de l'Education Nationale) prospective cohort study.
    Dow C; Mangin M; Balkau B; Affret A; Boutron-Ruault MC; Clavel-Chapelon F; Bonnet F; Fagherazzi G
    Br J Nutr; 2016 Nov; 116(10):1807-1815. PubMed ID: 27842617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial cancer risk with menopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
    Yuk JS
    Int J Gynaecol Obstet; 2023 Aug; 162(2):502-513. PubMed ID: 36964935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of progestogens used in Menopausal Hormone Therapy (MHT)].
    Mueck AO
    Ther Umsch; 2021; 78(8):447-455. PubMed ID: 34555976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.
    Trémollieres FA; Chabbert-Buffet N; Plu-Bureau G; Rousset-Jablonski C; Lecerf JM; Duclos M; Pouilles JM; Gosset A; Boutet G; Hocke C; Maris E; Hugon-Rodin J; Maitrot-Mantelet L; Robin G; André G; Hamdaoui N; Mathelin C; Lopes P; Graesslin O; Fritel X
    Maturitas; 2022 Sep; 163():62-81. PubMed ID: 35717745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.